Late Breaking Clinical Science Abstracts

437 - First Long-Term 5-years Experience with the HeartMate 3 LVAS in Multicentric Clinical Trial

Presentation Number
437
Speakers
Session Name
MINI ORAL 08 - MINI ORAL SESSION: Factors Influencing Outcome after LVAD Implantation
Date
Thu, Apr 23, 2020
Time
06:15 PM - 07:15 PM
Authors
Audio Upload

Previous ePresentation
436 - Increased Morbidity and Mortality with Concomitant Aortic Valve Surgery in Patients Receiving a Continuous-Flow Left Ventricular Assist, an IMACS Database Analysis

Next ePresentations
438 - The Impact of HeartMate 3 Speed on Outcomes in the Momentum 3 Clinical Trial
442 - Mortality in Patients with Cardiogenic Shock Supported with Veno-Arterial Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis Evaluating the Impact of Etiology
450 - Acute and Chronic Pre-Clinical Implants of the CorWave LVAD: Hydraulic, Hemocompatibility and Hemodynamic Results
451 - Assessment of Arrhythmia Burden through the Use of an Implantable Cardiac Monitor in Patients with a Continuous Flow Left Ventricular Assist Device
454 - Molecular Assessment of Single-Piece Mucosal Biopsies is Highly Reproducible Compared to Transbronchial Biopsies in Lung Transplantation
456 - Survival Outcomes of Lung Transplant Recipients from Donors with Abnormal Kidney Function
457 - Survival Outcomes of Lung Transplant Recipients from Donors with High Body Mass Index
466 - Complement Inhibition as Potential Novel Therapy for Antibody-Mediated Rejection after Lung Transplantation in Murine Antibody-Mediated Rejection Model
478 - Incidence of Driveline Infections and Sepsis in a Contemporary HVAD Population
481 - Acute Infection Disrupts the Respiratory Microbiome of Lung Transplant Recipients